---
title: "Fluidx Medical announces US FDA approval for embolic device clinical trial"
date: "2024-05-21T09:22:49.000Z"
publishedDate: "21 mai 2024"
summary: "Fluidx Medical Technology has announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval to initiate the GPX embolic device pivotal clinical trial. The objective of this trial will be to evaluate the safety and effectiveness of the GPX embolic device."
importance: ""
sourceUrl: "https://interventionalnews.com/fluidx-medical-announces-us-fda-approval-for-embolic-device-clinical-trial/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2024-05-21-fluidx-medical-announces-us-fda-approval-for-embolic-device-clinical-trial"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2024/05/GPX-Image-zoomed.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/fluidx-medical-announces-us-fda-approval-for-embolic-device-clinical-trial/"
---

![Fluidx Medical announces US FDA approval for embolic device clinical trial](https://interventionalnews.com/wp-content/uploads/sites/13/2024/05/GPX-Image-zoomed.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/fluidx-medical-announces-us-fda-approval-for-embolic-device-clinical-trial/*

## L’essentiel

Fluidx Medical Technology has announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval to initiate the GPX embolic device pivotal clinical trial. The objective of this trial will be to evaluate the safety and effectiveness of the GPX embolic device.

## Lien source

https://interventionalnews.com/fluidx-medical-announces-us-fda-approval-for-embolic-device-clinical-trial/
